What does DR. GINO NAESSENS do?

DR. GINO NAESSENS is a specialist medical practice in Kasterlee. Private Limited, started on 13 December 2002.

What is the address of DR. GINO NAESSENS?

The registered office of DR. GINO NAESSENS is located at Akkerstraat 60, 2460 Kasterlee.

Is DR. GINO NAESSENS still active?

Yes. According to the CBE (30 October 2026) DR. GINO NAESSENS is active, legal situation “Normale toestand”, started on 13 December 2002.

Is DR. GINO NAESSENS registered on Peppol?

Yes, DR. GINO NAESSENS is registered on the Peppol network with ID 0208:0479033213.

What is the enterprise number of DR. GINO NAESSENS?

The enterprise number of DR. GINO NAESSENS is BE0479033213.

When was DR. GINO NAESSENS founded?

DR. GINO NAESSENS was founded on 13 December 2002.

Who are the directors of DR. GINO NAESSENS?

According to the 2025 annual accounts, the directors of DR. GINO NAESSENS are: Giovanni Naessens.

Is DR. GINO NAESSENS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 December 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. GINO NAESSENS make in 2025?

DR. GINO NAESSENS posted a profit after taxes of € 80,133 in financial year 2025.

What is the revenue of DR. GINO NAESSENS?

As a small company, DR. GINO NAESSENS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 135,791.

DR. GINO NAESSENS (Private Limited) - Kasterlee

Dossier DR. GINO NAESSENS, printed on 30 October 2026 from databakkes.be/en/0479033213/dr-gino-naessens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. GINO NAESSENS from Kasterlee, company number BE0479033213, closed financial year 2025 with a result of € 80,133 after tax. For that financial year DR. GINO NAESSENS recorded a gross margin of € 135,791 and equity of € 430,930. Compared with financial year 2024, the result moved from € 102,534 to € 80,133. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.

What it is worth Growing

€ 430,930

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 80,133

▼ 22% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 393,959

▲ 62% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 27,249 paid out

34 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 53,135

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,848

▲ 232% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,900

▼ 58% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 167,396 Gross margin 2022: € 167,396 First fiscal year in the series	€ 196,879 Gross margin 2023: € 196,879 ▲ 18% vs 2022 (€ 167,396) Favourable step	€ 157,914 Gross margin 2024: € 157,914 ▼ 20% vs 2023 (€ 196,879) Unfavourable step	€ 135,791 Gross margin 2025: € 135,791 ▼ 14% vs 2024 (€ 157,914) Unfavourable step	▼ 14%
Profit after taxes	€ 108,189 Profit after taxes 2022: € 108,189 First fiscal year in the series	€ 124,192 Profit after taxes 2023: € 124,192 ▲ 15% vs 2022 (€ 108,189) Favourable step	€ 102,534 Profit after taxes 2024: € 102,534 ▼ 17% vs 2023 (€ 124,192) Unfavourable step	€ 80,133 Profit after taxes 2025: € 80,133 ▼ 22% vs 2024 (€ 102,534) Unfavourable step	▼ 22%
Equity	€ 270,538 Equity 2022: € 270,538 First fiscal year in the series	€ 330,057 Equity 2023: € 330,057 ▲ 22% vs 2022 (€ 270,538) Favourable step	€ 378,046 Equity 2024: € 378,046 ▲ 15% vs 2023 (€ 330,057) Favourable step	€ 430,930 Equity 2025: € 430,930 ▲ 14% vs 2024 (€ 378,046) Favourable step	▲ 14%
Total debts	€ 295,038 Total debts 2022: € 295,038 First fiscal year in the series	€ 230,172 Total debts 2023: € 230,172 ▼ 22% vs 2022 (€ 295,038) Favourable step	€ 188,175 Total debts 2024: € 188,175 ▼ 18% vs 2023 (€ 230,172) Favourable step	€ 126,625 Total debts 2025: € 126,625 ▼ 33% vs 2024 (€ 188,175) Favourable step	▼ 33%
Cash	€ 463,253 Cash 2022: € 463,253 First fiscal year in the series	€ 453,224 Cash 2023: € 453,224 ▼ 2% vs 2022 (€ 463,253) Unfavourable step	€ 242,688 Cash 2024: € 242,688 ▼ 46% vs 2023 (€ 453,224) Unfavourable step	€ 393,959 Cash 2025: € 393,959 ▲ 62% vs 2024 (€ 242,688) Favourable step	▲ 62%
Retained profit	€ 240,538 Retained profit 2022: € 240,538 First fiscal year in the series	€ 300,057 Retained profit 2023: € 300,057 ▲ 25% vs 2022 (€ 240,538) Favourable step	€ 348,046 Retained profit 2024: € 348,046 ▲ 16% vs 2023 (€ 300,057) Favourable step	€ 400,930 Retained profit 2025: € 400,930 ▲ 15% vs 2024 (€ 348,046) Favourable step	▲ 15%
Dividend	€ 131,189 Dividend 2022: € 131,189 First fiscal year in the series	€ 64,674 Dividend 2023: € 64,674 ▼ 51% vs 2022 (€ 131,189) Unchanged	€ 54,545 Dividend 2024: € 54,545 ▼ 16% vs 2023 (€ 64,674) Unchanged	€ 27,249 Dividend 2025: € 27,249 ▼ 50% vs 2024 (€ 54,545) Unchanged	▼ 50%
Balance sheet total	€ 565,577 Balance sheet total 2022: € 565,577 First fiscal year in the series	€ 560,229 Balance sheet total 2023: € 560,229 ▼ 1% vs 2022 (€ 565,577) Unchanged	€ 566,221 Balance sheet total 2024: € 566,221 ▲ 1% vs 2023 (€ 560,229) Unchanged	€ 557,555 Balance sheet total 2025: € 557,555 ▼ 2% vs 2024 (€ 566,221) Unchanged	▼ 2%

Key figures of DR. GINO NAESSENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. GINO NAESSENS?

What happened at DR. GINO NAESSENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 30, 2026 New annual accounts for financial year 2025: profit of € 80,133 (▼ 22% vs 2024). filed late Source: NBB ↗
Dec 13, 2002 Start of the company according to the CBE. KBO

In short

From € 108,189 profit in 2022 to € 80,133 profit in 2025.

Paid € 160,541 in corporate taxes since 2022.

Best year ever: 2023, with € 124,192 profit.

Paid out € 277,657 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Giovanni Naessens

DR. GINO NAESSENS

Behind DR. GINO NAESSENS is Giovanni Naessens.

Directors

According to the 2025 annual accounts

Giovanni Naessens

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Akkerstraat 60

2460 Kasterlee

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0479.033.213

VAT number

BE 0479.033.213

Registered office

Akkerstraat 60, 2460 Kasterlee

Names & denominations

DR. GINO NAESSENS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

13 December 2002

Peppol

Active · Active since 5 Dec 2025

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten op het gebied van kinesitherapie

Ambulante revalidatieactiviteiten

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. GINO NAESSENS

Financials

What happened to DR. GINO NAESSENS?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions